Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06343051 · ClinicalTrials.gov registry record
USCOM in Newly Diagnosed FGR Cases
A clinical trial of Fetal Growth Restriction and USCOM, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06343051 is a study of Fetal Growth Restriction and USCOM that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06343051, a study of Fetal Growth Restriction and USCOM, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
Conditions Studied
Interventions
- DEVICE USCOM
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06343051
The ClinicalTrials.gov registry entry for NCT06343051 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fetal Growth Restriction appearing as the primary indexed condition, and to 1 intervention - of which USCOM is the first listed.
NCT06343051 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06343051 about?
NCT06343051 is a clinical study titled "USCOM in Newly Diagnosed FGR Cases". The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding t...
What is the current status of trial NCT06343051?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-07-02. Estimated completion is 2026-06.
What conditions does trial NCT06343051 study?
This clinical trial studies the following conditions: Fetal Growth Restriction, USCOM.
What interventions are being tested in trial NCT06343051?
The interventions under investigation include: USCOM (DEVICE).
Who is sponsoring clinical trial NCT06343051?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06343051 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Growth Restriction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.